Related Experiment Video
Updated: Mar 26, 2026
Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
Published on: March 17, 2023
Hematopoietic Stem Cells Transplantation Can Normalize Thyroid Function in a Cystinosis Mouse Model.
H P Gaide Chevronnay1, V Janssens1, P Van Der Smissen1
1Cell Biology Unit (H.P.G.C., V.J., P.V.D.S., C.E.P., P.J.C.), de Duve Institute and Université Catholique de Louvain, 1200 Brussels, Belgium; Department of Pediatrics (C.J.R., S.C.), Division of Genetics, University of California, San Diego, San Diego, California 92161; and Departments of Medicine (X.H.L., S.R.) and Pediatrics and Genetics (S.R.), The University of Chicago, Chicago, Illinois 60637.
Hematopoietic stem cell (HSC) transplantation successfully treated hypothyroidism in cystinosis mouse models. This therapy corrects thyroid function by transferring cystinosin-bearing lysosomes, offering a potential multisystemic treatment for this rare genetic disease.
Area of Science:
- Endocrinology
- Genetics
- Cell Biology
Background:
- Cystinosis is a lysosomal storage disease leading to hypothyroidism, often due to defective cystine transport.
- Previous studies in Ctns(-/-) mice showed altered thyroglobulin biosynthesis and lysosomal processing contribute to hypothyroidism.
- Hematopoietic stem cell (HSC) transplantation demonstrated protective effects in the kidneys of Ctns(-/-) mice.
Purpose of the Study:
- To evaluate the efficacy of HSC transplantation in treating thyroid dysfunction in cystinosis.
- To investigate the mechanisms by which HSCs impact the thyroid microenvironment in cystinosis.
Main Methods:
- HSC transplantation was performed in Ctns(-/-) mice with cystinosis.
- Thyroid function, cystine accumulation, and TSH levels were assessed post-transplantation.
- HSC differentiation, cell-cell interactions, and lysosome transfer mechanisms were analyzed in the thyroid microenvironment.
Main Results:
- HSC transplantation significantly reduced cystine accumulation and normalized TSH levels in the thyroid.
- Grafted HSCs differentiated into macrophage/dendritic cell lineages and formed tunneling nanotubes, facilitating contact with thyrocytes.
- Thyroid structure was corrected in a significant portion of thyrocytes, despite differences in basement lamina porosity compared to the kidney.
Conclusions:
- HSC transplantation is a promising therapeutic strategy for correcting thyroid disease in cystinosis.
- The study highlights the potential for stem cell therapy to address multisystemic complications of cystinosis.
- Mechanisms involve direct cell-cell contact and lysosome transfer, suggesting a novel approach to treating lysosomal storage diseases.
